Literature DB >> 1736885

Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.

L M Forrester1, C J Henderson, M J Glancey, D J Back, B K Park, S E Ball, N R Kitteringham, A W McLaren, J S Miles, P Skett.   

Abstract

Cytochrome P450s play a central role in the metabolism and disposition of an extremely wide range of drugs and chemical carcinogens. Individual differences in the expression of these enzymes may be an important determinant in susceptibility to adverse drug reactions, chemical toxins and mutagens. In this paper, we have measured the relative levels of expression of cytochrome P450 isoenzymes from eight gene families or subfamilies in a panel of twelve human liver samples in order to determine the individuality in their expression and whether any forms are co-regulated. Isoenzymes were identified in most cases on Western blots based on the mobility of authentic recombinant human cytochrome P450 standards. The levels of the following P450 proteins correlated with each other: CYP2A6, CYP2B6 and a protein from the CYP2C gene subfamily, CYP2E1 and a member of the CYP2A gene subfamily, CYP2C8, CYP3A3/A4 and total cytochrome P450 content. Also, the levels of two proteins in the CYP4A gene subfamily were highly correlated. These correlations are consistent with the relative regulation of members of these gene families in rats or mice. In addition, the level of expression of specific isoenzymes has also been compared with the rate of metabolism of a panel of drugs, carcinogens and model P450 substrates. These latter studies demonstrate and confirm that the correlations obtained in this manner represent a powerful approach towards the assignment of the metabolism of substrates by specific human P450 isoenzymes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1736885      PMCID: PMC1130692          DOI: 10.1042/bj2810359

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  70 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Glutathione S-transferase and glutathione peroxidase expression in normal and tumour human tissues.

Authors:  A F Howie; L M Forrester; M J Glancey; J J Schlager; G Powis; G J Beckett; J D Hayes; C R Wolf
Journal:  Carcinogenesis       Date:  1990-03       Impact factor: 4.944

3.  Purification of human liver cytochrome P-450 catalyzing testosterone 6 beta-hydroxylation.

Authors:  S Kawano; T Kamataki; T Yasumori; Y Yamazoe; R Kato
Journal:  J Biochem       Date:  1987-09       Impact factor: 3.387

4.  Identification of human cytochromes P-450 analogous to forms induced by phenobarbital and 3-methylcholanthrene in the rat.

Authors:  D J Adams; S Seilman; Z Amelizad; F Oesch; C R Wolf
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

5.  Mephenytoin hydroxylation polymorphism: characterization of the enzymatic deficiency in liver microsomes of poor metabolizers phenotyped in vivo.

Authors:  U T Meier; P Dayer; P J Malè; T Kronbach; U A Meyer
Journal:  Clin Pharmacol Ther       Date:  1985-11       Impact factor: 6.875

6.  Genetic polymorphism of human cytochrome P-450 (S)-mephenytoin 4-hydroxylase. Studies with human autoantibodies suggest a functionally altered cytochrome P-450 isozyme as cause of the genetic deficiency.

Authors:  U T Meier; U A Meyer
Journal:  Biochemistry       Date:  1987-12-15       Impact factor: 3.162

7.  Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues.

Authors:  I de Waziers; P H Cugnenc; C S Yang; J P Leroux; P H Beaune
Journal:  J Pharmacol Exp Ther       Date:  1990-04       Impact factor: 4.030

8.  Testosterone-mediated regulation of mouse renal cytochrome P-450 isoenzymes.

Authors:  C J Henderson; A R Scott; C S Yang; C R Wolf
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

Review 9.  The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature.

Authors:  D W Nebert; D R Nelson; M J Coon; R W Estabrook; R Feyereisen; Y Fujii-Kuriyama; F J Gonzalez; F P Guengerich; I C Gunsalus; E F Johnson
Journal:  DNA Cell Biol       Date:  1991 Jan-Feb       Impact factor: 3.311

10.  Pattern of serum protein gene expression in mouse visceral yolk sac and foetal liver.

Authors:  R R Meehan; D P Barlow; R E Hill; B L Hogan; N D Hastie
Journal:  EMBO J       Date:  1984-08       Impact factor: 11.598

View more
  44 in total

1.  The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liver.

Authors:  Janet K Coller; Niels Krebsfaenger; Kathrin Klein; Karin Endrizzi; Renzo Wolbold; Thomas Lang; Andreas Nüssler; Peter Neuhaus; Ulrich M Zanger; Michel Eichelbaum; Thomas E Mürdter
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

2.  Enhanced urinary angiotensinogen excretion in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.

Authors:  Carlo J Milani; Hiroyuki Kobori; John J Mullins; Kenneth D Mitchell
Journal:  Am J Med Sci       Date:  2010-11       Impact factor: 2.378

3.  Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues.

Authors:  Tracy C Delozier; Grace E Kissling; Sherry J Coulter; Diana Dai; Julie F Foley; J Alyce Bradbury; Elizabeth Murphy; Charles Steenbergen; Darryl C Zeldin; Joyce A Goldstein
Journal:  Drug Metab Dispos       Date:  2007-01-12       Impact factor: 3.922

4.  Defining the in Vivo Role for cytochrome b5 in cytochrome P450 function through the conditional hepatic deletion of microsomal cytochrome b5.

Authors:  Robert D Finn; Lesley A McLaughlin; Sebastien Ronseaux; Ian Rosewell; J Brian Houston; Colin J Henderson; C Roland Wolf
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

5.  Chronic direct renin inhibition with aliskiren prevents the development of hypertension in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent hypertension.

Authors:  Lily Huang; Catherine G Howard; Kenneth D Mitchell
Journal:  Am J Med Sci       Date:  2012-10       Impact factor: 2.378

Review 6.  Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.

Authors:  M Pirmohamed; S Madden; B K Park
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

7.  Evidence for a role of cytochrome P450 2D6 and 3A4 in ethylmorphine metabolism.

Authors:  Z Liu; O Mortimer; C A Smith; C R Wolf; A Rane
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

8.  A novel panel of mouse models to evaluate the role of human pregnane X receptor and constitutive androstane receptor in drug response.

Authors:  Nico Scheer; Jillian Ross; Anja Rode; Branko Zevnik; Sandra Niehaves; Nicole Faust; C Roland Wolf
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

Review 9.  CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme.

Authors:  Hongbing Wang; Leslie M Tompkins
Journal:  Curr Drug Metab       Date:  2008-09       Impact factor: 3.731

Review 10.  Cyclophosphamide and cancer: golden anniversary.

Authors:  Ashkan Emadi; Richard J Jones; Robert A Brodsky
Journal:  Nat Rev Clin Oncol       Date:  2009-09-29       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.